Explore the Global Bone Morphogenetic Protein Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Bone Morphogenetic Protein Market

Key Insight

Bone morphogenetic protein sales will strengthen through 2036, anchored by rhbmp-2 at 55.1% of the type segment in 2026, driven by established clinical adoption and regulatory approval for orthopedic procedures. The market was valued at USD 358.0 million in 2025 and is expected to be worth USD 605.92 million by 2036.

May 13, 2026

Anurag Sharma

250 Pages

Cite this Report

Bone Morphogenetic Protein Market

https://www.futuremarketinsights.com/reports/bone-morphogenetic-protein-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Bio-Techne
Cell Guidance Systems LLC
Cellumed Co. Ltd
Emerging Players Thermo Fisher Scientific Inc
Medtronic plc
Merck KGaA
Prospec-Tany Technogene Ltd
Proteintech Group
Qkine Ltd
STEMCELL Technologies Inc
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Bone Morphogenetic Protein Market

Key Players

Similar Industry Reports